We describe a novel experimental system in mice for the study of ovarian autoimmune disease, a condition encountered in women with premature ovarian failure. The ovarian autoimmune disease is induced in B6AF1 mice by a 15-amino acid peptide (Cys-Ser-Asn-Ser-Ser-Ser-Ser-Gln-Phe-Gln-Ile-His-Gly-Pro-Arg) from mouse ZP3, the sperm-binding component of the zona pellucida that surrounds growing and mature oocytes. Whereas the peptide induces both T cell and antibody responses, adoptive transfer of CD4+ T cell lines derived from affected animals causes oophoritis without observable antibodies to the zona pellucida peptide. The primacy of the T cell response in the pathogenesis of disease is further substantiated by defining oophoritogenic peptides as small as eight amino acids (Asn-Ser-Ser-Ser-Ser-Gln-Phe-Gln) that do not elicit an antibody response to the full-length ZP3 peptide. The identification of a well characterized peptide as a causative agent of autoimmune oophoritis should facilitate understanding of the pathogenesis of this T cellmediated autoimmune disease. Because the proteins of the zona pellucida are conserved among mammals (the mouse and human ZP3 proteins are 67% identical), this murine model may lead to better understanding of the pathogenesis of human autoimmune oophoritis.
Introduction
Human autoimmune oophoritis is a pathologic entity encountered in women with premature ovarian failure (1, 2) , the polyglandular autoimmunity syndrome, (3) and cystic ovarian disease (4) . A comparable disease, murine autoimmune oophoritis, has been described in certain strains of female mice [(C57BL/6 X A/J)F1, (SWR/J X A/J)F,, BALB/cBy], thymectomized between 1 and 4 d after birth. Initial inflammatory infiltrations in the ovary culminate in intense oophoritis between 5 and 14 wk and eventually the loss of ova and the collapse of ovarian follicles results in grossly atrophic ovaries.
Animals with sham thymectomies do not develop disease (5) (6) (7) . Since neonatal thymectomy of(C57B1/6 X A/J)F1 results in the maintenance of at least one T cell receptor (V. 11+) that would otherwise be clonally deleted in the adult thymus, it raises the possibility that the oophoritis may occur because of enrichment of self-reactive T cells from the neonatal repertoire (8) .
Investigations into the pathogenesis of autoimmune oophoritis has been hampered by the lack of an identifiable initiating antigen(s). We have sought to identify potential target antigens in the ovary in order to establish an experimental system to study the pathogenesis ofmurine autoimmune oophoritis in thymus intact animals. One source for such antigens is the zona pellucida, an extracellular matrix surrounding growing oocytes that is composed of three sulfated glycoproteins, ZP 1, ZP2, and ZP3 (9, 10) . ZP3 (83 kD) acts as the primary sperm receptor, mediating sperm binding to ovulated eggs and inducing the sperm acrosome reaction at the time of fertilization (1 1). The single-copy Zp-3 gene (12, 13) is transcribed uniquely in growing oocytes (14, 15) and the resultant protein can be detected in ovaries within 3 d of birth. The 424-amino acid sequence of ZP3 has been deduced from a full-length cDNA (16) and is 67% identical to the recently described human ZP3 protein (17) .
In this paper we describe the induction of ovarian autoimmune disease in B6AF, mice with a 15-amino acid oophoritogenic peptide, ZP3328342. In transfer studies to naive animals we demonstrate the pathogenetic role of T cells in eliciting disease and, using truncated peptides, define an eight-amino acid peptide as a minimal oophoritogenic peptide.
Methods
Animals. (C57BL/6 X A/J)F, (B6AFI), A/J, C57BL/6 (B6), and BALB/ cBy adult female mice were obtained from the Jackson Laboratory, Bar Harbor, ME, or from Washington University School of Medicine. Random bred NIH Swiss mice were housed at the National Institutes of Health. Mice were studied at 6-9 wk of age. Peptides. ZP3 peptides were synthesized by solid-phase synthesis and purified by high pressure liquid chromatography on a C 18 reversephase column. Peptide composition was verified by amino acid analysis. The results of studies based on peptide ZP332842 (CSNSSSSQF-QIHGPR, mol wt 1,615) and peptide ZP3328-34 (CSNSSSSQFQIH-GPRQ, mol wt 1,743) were indistinguishable and the two peptides were used interchangeably in the study. Additional truncated 328-342 peptides are listed in Fig. 1 . As controls, mice were immunized with mouse ZP3 peptides encompassing residues 183-196 (peptide A, EK-SAPTFHLGEVAH), residues 201-221 (peptide B, HLPLQLFVD-HCVATPS), and residues 371-398 (peptide C, KANDQTVEGWTA-SAQTS). Mycobacterial antigen was prepared by suspending 200 mg of lyophilized Mycobacterium tuberculosis organisms (H37Ra, Difco Lab- oratories, Inc., Detroit, MI) in 2 ml of PBS. The solution was sonicated and clarified by microfugation. Immunization. The appropriate dose ofpeptide dissolved in deionized/distilled water, was emulsified in an equal volume of complete Freund's adjuvant containing 4.5 mg/ml Mycobacterium tuberculosis or incomplete Freund's adjuvant. Each mouse received 0.1 ml of the antigen and adjuvant emulsion in the two hind footpads. Some mice also received intraperitoneally 5 Ag of an extract ofBordetella pertussis enriched in pertussigen (gift of Dr. John Munoz, National Institute of Allergy and Infectious Disease, Hamilton, MT) (18) .
Histologic assessment ofovarian disease. Ovaries were fixed for 24 h in Bouin's fixative and embedded in paraffin. Approximately 50 serial step sections (5 Am) stained with hematoxylin and eosin were examined. Histopathology of ovaries, as coded specimens, were evaluated by an independent observer. Ovarian pathology was graded with increasing severity from 1 to 4 (1, focal inflammation in interstitial space; 2 and 3, increasing multifocal inflammatory foci and/or granuloma between and within ovarian follicles; 4, loss of ovarian follicles and ovarian atrophy).
Antigen-specific lymphocyte proliferation assay. Popliteal and inguinal lymph nodes were dispersed into single cell suspension in RPMI-1640 medium supplemented with 1% sodium pyruvate, 1% nonessential amino acids, 1% 200 mM glutamine, 100 U of penicillin, 100 Mg/ml streptomycin, 5 x 10-5 M 2-mercaptoethanol, and 10% heat-inactivated fetal calf serum (Fisher Scientific Co., Pittsburgh, PA) (complete medium). Cells were cultured in flat-bottom microtiter plates (Costar, Cambridge, MA) at 3 x 105 cells per well in a volume of 0.2 ml in the presence of varying concentrations of filter-sterilized ZP3 peptides or mycobacterial antigens. Mycobacterial antigen was diluted 1:100 in complete medium and 50 Ml were used per well. After 4 d in 370C in 5% CO2 and air, 0.5 MCi of [3H]thymidine was added and the amount of cell-associated thymidine determined 8 h later. Data were expressed as delta counts per min (experimental counts per minute minus background counts per minute) and as a stimulation index (experimental counts per minute divided by background counts per minute). Background was calculated from cells not stimulated with peptide.
Production of Tcell lines. B6AF, female mice were immunized with 100 Mg of ZP332>340 or ZP3331342 in complete Freund's adjuvant. 14 d later, their lymph node cells were isolated and stimulated in vitro with 30 AM 328-342 in complete medium. 4 d later, viable lymphocytes were obtained by centrifugation on a Hypaque-Ficoll gradient and dispersed in complete medium with 1-2% oflymphokine-enriched supernatant of EL4 cell culture containing 1.5 U of interleukin 2 activity. After 7-10 d, the lymphocytes were restimulated with 30 MM of ZP3328342 in complete medium and rested, as described above. After four cycles of alternating peptide stimulation and resting period, two stable cell lines ofCD4+CD8-phenotype were obtained that responded specifically to ZP332832.
Adoptive transfer of oophoritis. B6AF1 female mice were immunized with 50 MM of ZP3328342 in complete Freund's adjuvant in the hind footpads. 10 d later, the inguinal, popliteal, subscapular, and paraaortic lymph nodes were dissected and from them viable lymph node cells were obtained. The cells were stimulated at 5 x 106/ml in complete medium in the presence of concanavalin A (3 ug/ml) for 48 h. Viable cells containing the activated T cell blasts were harvested by centrifugation on a Hypaque-Ficoll gradient, washed, and transferred intraperitoneally into untreated adult B6AF, female recipients. T cell lines having just been stimulated by ZP33281-32 were similarly transferred into untreated adult B6AF1 female recipients. Ovaries of cell recipients were studied histologically 14 d later.
Detection of serum antibody to peptide Zp3328-342. Each well of a 96-well flat bottom plate (Costar ELISA plate) was coated by 100 Ml ofa 10 AM ZP3328342 peptide solution and blocked by 2% bovine serum albumin in phosphate-buffered saline (PBS). Test serum triplicates at 1:50 and 1:200 dilutions were added and incubated for 60 min at 20'C. ZP3 Peptide-induced Autoimmune Oophoritis 29
The plates were washed six times with PBS and 0.05% Tween 20, and incubated with goat anti-mouse immunoglobulins labeled with peroxidase (Amersham Corp., Arlington Heights, IL) (1:1,000) for 60 min at 20'C. After the plates were washed thoroughly, O-phenylenediamine and hydrogen peroxide were added. Enzyme reaction was stopped by 2.5 N sulfuric acid after 15-30 min, and the absorbance at 490 nm was determined on an ELISA reader. A standard curve was constructed with serial dilutions of a pooled hyperimmune antiserum against ZP3328342 and the experimental values expressed as the percent of the midpoint of the standard curve.
Direct immunofluorescence. Ovaries were snap frozen in liquid nitrogen and embedded in OCT compound, and 5-tim-thick frozen sections were cut in a cryostat. After the tissue sections were fixed in 90% ethanol for 15 min, they were rinsed in PBS and incubated with fluorescein isothiocyanate-conjugated goat antiserum IgG containing antibody to mouse immunoglobulins (IgG, IgA, or IgM), mouse IgGFc, or mouse IgM (Southern Biotechnology, Birmingham, AL) for 30 min. After the sections were rinsed in PBS followed by glycerol containing 10% PBS, a coverslip was applied and the slides were examined and photographed with a Zeiss fluorescence microscope.
Results
Induction of murine autoimmune oophoritis by ZP3328342. Four ZP3 peptides (amino acids 183-196, 206-221, 336-351, 371-398), selected for their capacity to form a-helical structures, were tested for their ability to induce oophoritis ( Fig. 1  A) . None elicited disease. However, a fifth peptide (amino acids 328-343) was a potent inducer of oophoritis in B6AF1, (C57BL/6 X A/J)F,, mice (Table I , expt. 1). This peptide (ZP33281-2) contains the seven-amino acid binding site of an anti-ZP3 monoclonal antibody that causes infertility in female mice (19) . When coupled to keyhole limpet hemocyanin, ZP3328-343 produces infertility in NIH Swiss mice without detectable ovarian disease (20) .
In contrast, when B6AF, mice were immunized with 50 nmol (85 ,ug) ofZP3328-2 in complete Freund's adjuvant, 48 of 56 (86%) developed oophoritis after a single injection (Table I , expt. 1). Similar results were obtained with ZP3328-343 and the two peptides were used interchangeably as noted. The disease began on day 6 with mild focal infiltrations of lymphoid cells confined to the interstitial spaces. By 10 d the disease prevalence was 85% (Table I, expt. 2) and granulomatous nodules had developed in the interstitium with a central cluster ofmacrophages surrounded by lymphocytes. Later in the disease, ovarian follicles were infiltrated by inflammatory cells (lymphocytes, macrophages, neutrophils, multinucleated giant cells) and the largest follicles (antral) had inflammatory cells among granulosa cells, adjacent to the zona pellucida and inside the oocytes. In contrast, primary follicles and luteal follicles were free of inflammation. By 21 d, in ovaries with severe disease, most of the large ovarian follicles were lost and the ovaries had become atrophic (Fig. 2) .
Moderate disease was found in three ofthree animals immunized with 10 nmol (17.5 Ag) of ZP3328-342 peptide and only mild ovarian pathology was found in two ofthree mice immunized with 2 nmol (3.5 ,ug) of the peptide ( (20) .
Immune response to ZP3328-342. Lymphocytes, isolated from female B6AF, mice immunized with ZP332342 in complete Freund's adjuvant, proliferated in response to ZP3328342 but not to two control ZP3 peptides (Fig. 3) . The earliest response was detected 3 d after immunization, several days before the onset of oophoritis, and coincided with the earliest lymphocyte proliferative response to mycobacterial antigen, a component of complete Freund's adjuvant. Lymphocytes from female B6AF1 immunized with ZP332142 in incomplete Freund's adjuvant also proliferated in response to ZP33242 (data not shown). Serum antibodies to solubilized ZP3328342 peptide were detected 10 d after immunization and were present in B6AF, female mice immunized with 50 nmol of ZP332-342 in complete Freund's adjuvant (Table II) . In addition to serum antibodies, IgG (but not IgM) binding to intraovarian zonae pellucidae was detected in ovaries ofmice immunized with ZP3321342 in complete Freund's adjuvant ( Fig. 4 A) or incomplete Freund's adjuvant ( Fig. 4 C) . Adoptive transfer ofmurine autoimmune oophoritis. To investigate the role of T cells in murine autoimmune oophoritis, lymph node cells from B6AF1 female mice immunized with ple granulomas and heavy lymphocytic infiltrates were noted in ovaries of all recipients ( Fig. 5 A, Table II ). In contrast, recipients of concanavalin A-activated lymph node cells from adjuvant alone immunized donors were normal. Two CD4+ T cell lines (ZP3A and ZP3B) were derived from B6AF, female mice immunized either with ZP3328-340 and ZP333342 , respectively, by repeated stimulation of lymph node cells with ZP3328-342 and IL-2. After stimulation by ZP332-42 or concanavalin A in culture, -1.1-1.5 X 107 cells were transferred to normal B6AFI female recipients. Recipients developed oophoritis comparable in severity to those of the cell donors ( Fig. 5 B, Table II ). Antibodies against the ZP3328-342 peptide were not detected in the sera nor were antibodies against the zona pellucida detected in ovaries of the recipients that developed oophoritis. Mapping smaller oophoritogenic epitopes. By studying peptides truncated at either the amino or carboxyl terminus ofthe ZP3328-342, oophoritogenic epitopes were mapped to regions as small as eight amino acids, ZP331337 (Fig. 1 B, Table III) . Two truncated peptides, ZP3328-336 and ZP3331-339, did not elicit disease in mice and did not stimulate a lymphocyte proliferative response in either lymph node cells or in each of two CD4' T cell lines derived from mice immunized with the original peptide ZP3328-342. As anticipated, mice immunized with these peptides did not produce antibodies to ZP3328 2. In these two non-pathogenic peptides, a single amino acid has been deleted from the amino or carboxyl boundary of the peptide, ZP331337. Thus, ZP331337 likely represents the most potent minimal oophoritogenic epitope within ZP332-342. There were eight truncated peptides that caused disease but did not elicit antibodies to the peptide in affected animals (Table III). The incidence and severity of disease elicited by the truncated oophoritogenic peptides varied from mild (ZP3332-342) to severe (e.g., ZP333032, ZP33131). Seven of these peptides stimulated a lymphocyte proliferative response in vitro in each oftwo T cell lines derived from affected animals (although only five elicited an positive response in lymph node cells derived from B6AFI immunized with ZP3321342, Table II ).
Only the smallest oophoritogenic peptide, ZP3330-337, did not stimulate either lymph node cells or T cell lines to proliferate (Table III) . The reason for this is not clear, but may be related to differences in presentation of the epitope in vivo (to elicit disease) and in vitro (to assay for cell proliferation). Taken together, these data suggest that there are several epitopes between amino acids 330 and 340 that can cause disease. The precise amino acid residues in ZP331'2 critical for disease induction are currently under investigation.
High antibody titers were detected only in mice immunized with peptides containing the monoclonal antibody binding site (amino acids 336-342) and at least six additional amino acids which provided a THelpcr epitope (Table III) . In contrast, mice immunized with peptides lacking an intact monoclonal antibody binding site produced no or minimal antibody to ZP3328-342 (Table III) . Thus, the region 336-342 must be the (20) . Thus, both T cell and antibody responses are potentially important mechanisms in pathogenesis of murine autoimmune oophoritis. However, adoptive transfer ofdisease by lymph node cells and two CD4+ T cell lines derived from mice immunized with peptides ZP330-M2 and ZP3328-340 strongly suggests that the primary mechanism of the disease is T cell mediated. Whether lymph node cells from male mice immunized with ZP3 peptide also transfer oophoritis is under study. The absence of circulating antibodies to the peptides in the T cell recipients indicates that disease can occur without the involvement of antibodies. That a T cell response is sufficient for induction of murine autoimmune oophoritis was further substantiated by the study of truncated ZP3328-342 peptides. Seven peptides that lack the antibody binding site previously defined by responses of outbred Swiss mice, elicit severe oophoritis without concomitant antibody response to ZP3328-32 (Table II) . These peptides include a minimal oophoritogenic peptide of eight amino acids, ZP3330337, which overlaps the seven-amino acid antibody binding site (ZP3336-42) by two residues. Although a T cell mechanism alone is sufficient and antibody is not required for murine oophoritis, the present study has not determined whether antibody alone can also induce disease. The truncated peptides that do not contain the oophoritogenic epitope afford useful reagents with which to resolve this issue.
The study also begins to elucidate the nature of ZP3 target antigens for T cells in normal mouse ovaries. In that oophoritis develops in mice immunized with ZP3328-32, we surmise that endogenous ZP3 protein must be processed by antigen-presenting cells in the normal mouse ovaries. The antigen-presenting cells then present the peptide to the peptide-specific CD4+ T cell in vivo. Normal mouse ovaries contain abundant macrophages that constitutively express readily detectable class II MHC molecules (21) . They exist in interfollicular areas and inside atretic ovarian follicles, the frequent sites oftissue injury in autoimmune oophoritis. In contrast, class II MHC molecules have not been detected on oocytes in normal ovary (22) or in ovaries with murine autoimmune oophoritis (K. S. K. Tung, unpublished data).
Autoimmune disease involving the human ovary can occur in conjunction with autoimmune disease in other endocrine organs or as an isolated entity (1) (2) (3) 23) . In either event, the oophoritis is characterized by lymphocytic infiltration of the ovary that preferentially destroys mature follicles. As the disease progresses, the ovary becomes atrophic and this is associated clinically with premature ovarian failure and sterility. Ovarian autoantibodies are detected in the circulation of affected patients (24) and the relative contribution of antibody and T cell response to the ovarian disease remains obscure. Although human autoimmune oophoritis most likely results from diverse etiologies, the identification ofan oophoritogenic epitope in the zona pellucida of mice may lead to a better understanding of how autoimmune T cells mediate human ovarian autoimmune disease. Such investigations will be facilitated by the recent isolation of the human ZP3 gene and the definition of primary structure of the ZP3 protein (17) . Whether T cell response to the ZP3 peptide is important in the pathogenesis of oophoritis in neonatally thymectomized mice has not yet been fully investigated.
These studies have implications beyond the understanding of the pathogenesis of autoimmune oophoritis. Investigations designed to test the potential of zona pellucida as a target for immunocontraception have been complicated by the loss of ovarian function and development of ovarian histopathology after immunization with zona proteins (25) . Insofar as we have shown that immunization with a ZP3 peptide can result in oophoritis in mice, it is probable that the ovarian disease reported in other species represents the end stage of autoimmune oophoritis. Based on this and an earlier study (20) , we suggest that antibody to ZP3 may cause reversible infertility while T cell response to ZP3 is responsible for oophoritis. The precise definition of an oophoritogenic peptide in a region of ZP3 known to contain binding sites for antibodies against the zona pellucida should facilitate the rational design of contraceptive vaccines that will selectively induce antibodies but not cause T cell-mediated ovarian damage. Although the genetic variation in antibody response poses a potential problem for a ZP3 peptide vaccine, this may be overcome by conjugation of the peptide to an immunogenic carrier protein.
